Clinical Trial

Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial\] is to further explore the effectiveness and safety of oxelidine in the treatment of moderate to severe acute pain after orthopedic surgery. The main question it aims to answer is: Pain management after orthopaedic surgery provides more effective and safe drug options, provides new options for clinical treatment, and provides a scientific basis for clinical practice. Participants will be asked to pain score in the different time, treatments they'll be given and use optimal drug. Researchers will compare analgesic effect of oxelidine of different dose.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-19.
Status change: Not Yet Recruiting → Recruiting 2025-02-14
Trial Details
NCT Number NCT06320041
Lead Sponsor The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Conditions Postoperative Pain
Enrollment 162 participants
Start Date 2024-08-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-17